New approval gives hope to HIV patients with few remaining treatment options.

Takeaway

• The FDA announced marketing approval for lenacapavir, a novel, first-in-class antiviral medication for patients living with multidrug-resistant (MDR) HIV that cannot be successfully treated or adequately controlled with other available treatments.
• Lenacapavir received authorisation...